You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myelodysplastic/myeloproliferative neoplasms

Showing 1 - 25 of 2,885
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

Myeloproliferative Tumor, Chronic Neutrophilic Leukemia, MDS Trial in Tampa (Fedratinib Pill)

Recruiting
  • Myeloproliferative Neoplasm
  • +2 more
  • Fedratinib Pill
  • Tampa, Florida
    Moffitt Cancer Center
Jun 15, 2022

Myelodysplastic/Myeloproliferative Tumors, Adult Trial in Suzhou (venetoclax combined with azacitidine)

Enrolling by invitation
  • Myelodysplastic/Myeloproliferative Neoplasms
  • Adult
  • venetoclax combined with azacitidine
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Mar 7, 2022

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myeloproliferative Tumor Trial in Houston (Azacitidine, Quizartinib)

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
May 23, 2022

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • sargramostim
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2022

Healthy Volunteers of Fanconi Anemia, Myeloproliferative

Completed
  • Chronic Myeloproliferative Disorders
  • +3 more
  • microarray analysis
  • +8 more
  • Portland, Oregon
    Knight Cancer Institute at Oregon Health and Science University
Jun 30, 2022

Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

Completed
  • Myelodysplastic/Myeloproliferative Neoplasm
  • +2 more
  • Decidual stromal cells (DSC)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

Not yet recruiting
  • Clonal Cytopenia of Undetermined Significance
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +1 more
Oct 4, 2023

Myeloid Malignancy, Acute Myeloid Leukemia, MDS Trial in Rochester (Telehealth Serious Illness Care Program, Education Control)

Not yet recruiting
  • Myeloid Malignancy
  • +4 more
  • Telehealth Serious Illness Care Program
  • Education Control
  • Rochester, New York
    University of Rochester
May 24, 2023

MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Feb 16, 2023

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

Recruiting
  • Brain and Central Nervous System Tumors
  • +8 more
  • 3'-deoxy-3'-[18F]fluorothymidine
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 30, 2022

Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 18, 2022

MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

Recruiting
  • MDS/MPN
  • Azacitidine (AZA) with Ruxolitinib
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Apr 17, 2023

Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

Recruiting
  • Primary Myelofibrosis
  • +9 more
  • Observational
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 11, 2022

Tissue, Blood, and Body Fluid Sample Collection From Hematologic

Recruiting
  • Chronic Myeloproliferative Disorders
  • +7 more
  • biologic sample preservation procedure
  • cytology specimen collection procedure
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Oct 14, 2021

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts Trial (Biospecimen

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • Biospecimen Collection
  • +3 more
  • (no location specified)
Oct 27, 2022

Collecting and Storing Blood Samples From Patients With Cancer

Withdrawn
  • Brain and Central Nervous System Tumors
  • +10 more
    • (no location specified)
    Sep 20, 2021

    Blasts More Than 20 Percent of Bone Marrow Nucleated Cells, Blasts More Than 20 Percent of Peripheral Blood White Cells,

    Completed
    Has Results
    • Blasts More Than 20 Percent of Bone Marrow Nucleated Cells
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 18, 2022

    MDS, Myeloproliferative Tumors, Myelofibrosis Trial (Jaktinib, azacitidine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • (no location specified)
    Nov 29, 2021

    Myelodysplastic Syndrome, Myeloproliferative Tumors, Chronic Myelomonocytic Leukemia Trial in United States (other, drug,

    Recruiting
    • Myelodysplastic Syndrome
    • +4 more
    • Geriatric assessment (GA) pre-transplant
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Aug 24, 2022

    Myeloid Malignancy, MDS, Myelofibrosis Trial in Boston (Navitoclax, Venetoclax, Decitabine)

    Recruiting
    • Myeloid Malignancy
    • +4 more
    • Boston, Massachusetts
    • +2 more
    Jul 21, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +11 more
    • Health Promotion and Education
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Jul 24, 2023

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Myeloproliferative Tumor (MDS/MPN) Trial in Durham (ADCT-301)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Durham, North Carolina
      Duke University Health System
    Jan 10, 2022

    Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Tumor Overlap Syndrome Trial in Worldwide

    Recruiting
    • Myelofibrosis
    • +5 more
    • Birmingham, Alabama
    • +27 more
    Oct 17, 2022